MX2018000870A - Metodos y materiales para mejorar las respuestas inmunitarias y funciones de la barrera de piel y/o mucosa. - Google Patents

Metodos y materiales para mejorar las respuestas inmunitarias y funciones de la barrera de piel y/o mucosa.

Info

Publication number
MX2018000870A
MX2018000870A MX2018000870A MX2018000870A MX2018000870A MX 2018000870 A MX2018000870 A MX 2018000870A MX 2018000870 A MX2018000870 A MX 2018000870A MX 2018000870 A MX2018000870 A MX 2018000870A MX 2018000870 A MX2018000870 A MX 2018000870A
Authority
MX
Mexico
Prior art keywords
methods
skin
materials
immune responses
barrier function
Prior art date
Application number
MX2018000870A
Other languages
English (en)
Inventor
A Berkes Eva
T Monsul Nicholas
T Boehm Frederick
Original Assignee
Quorum Innovations Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quorum Innovations Llc filed Critical Quorum Innovations Llc
Publication of MX2018000870A publication Critical patent/MX2018000870A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/20—Bacteria; Substances produced thereby or obtained therefrom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/143—Fermentum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Dentistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)

Abstract

La presente invención proporciona composiciones y métodos para tratar condiciones dermatológicas humanas al emplear un enfoque de tratamiento centrado en microbiomas. Modalidades preferidas de la invención proporcionan composiciones farmacéuticas y cosméticas, y los métodos para usar las mismas, que comprenden una cepa de la bacteria Lactobacillus fermentum, o extractos bioactivos de la misma, derivados de la microbiota humana y capaces de crecer en fenotipo de biopelícula.
MX2018000870A 2015-07-20 2016-07-19 Metodos y materiales para mejorar las respuestas inmunitarias y funciones de la barrera de piel y/o mucosa. MX2018000870A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562194630P 2015-07-20 2015-07-20
PCT/US2016/042939 WO2017015275A1 (en) 2015-07-20 2016-07-19 Materials and methods for improving immune responses and the skin and/or mucosal barrier function

Publications (1)

Publication Number Publication Date
MX2018000870A true MX2018000870A (es) 2018-05-15

Family

ID=57835147

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018000870A MX2018000870A (es) 2015-07-20 2016-07-19 Metodos y materiales para mejorar las respuestas inmunitarias y funciones de la barrera de piel y/o mucosa.

Country Status (18)

Country Link
US (5) US9706778B2 (es)
EP (1) EP3324986B1 (es)
JP (1) JP6727285B2 (es)
KR (1) KR102258415B1 (es)
CN (1) CN108135947B (es)
AU (1) AU2016297539B9 (es)
BR (1) BR112018001187B1 (es)
CA (1) CA2991990C (es)
DK (1) DK3324986T3 (es)
ES (1) ES2904555T3 (es)
HK (1) HK1253067A1 (es)
HU (1) HUE057494T2 (es)
IL (1) IL256973B (es)
MX (1) MX2018000870A (es)
PL (1) PL3324986T3 (es)
PT (1) PT3324986T (es)
WO (1) WO2017015275A1 (es)
ZA (1) ZA201800209B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2463181B (en) 2007-05-14 2013-03-27 Univ New York State Res Found Induction of a physiological dispersion response in bacterial cells in a biofilm
KR102258415B1 (ko) * 2015-07-20 2021-05-28 쿼럼 이노베이션즈 엘엘씨 면역 반응 및 피부 및/또는 점막 장벽 기능을 개선하기 위한 물질 및 방법
CN110891651A (zh) * 2017-02-10 2020-03-17 毛里西奥·迪·马伊奥·杜明高斯 用于预防、矫正、变换和修改面部美学且关于其而咨询患者的方法和系统
US11253454B2 (en) * 2017-03-10 2022-02-22 Johnson & Johnson Consumer Inc. Method for affecting touch
GB201807576D0 (en) 2018-05-09 2018-06-20 Skinbiotherapeutics Plc Compositions and uses thereof
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
EP3685669A1 (en) * 2019-01-23 2020-07-29 Chrisal NV Composition for the decontamination and inoculation of surfaces
JP2023503350A (ja) 2019-11-26 2023-01-27 クオラム イノベーションズ リミテッド ライアビリティ カンパニー 新規な保護バリア組成物、およびその使用
MX2022013737A (es) * 2020-05-06 2022-11-16 Quorum Innovations Llc Nueva proteina y usos terapeuticos y cosmeticos de la misma.
KR102167387B1 (ko) * 2020-05-14 2020-10-19 코스맥스 주식회사 피부 장벽 강화, 피부 보습 또는 항노화를 위한 조성물
AU2021286002A1 (en) 2020-06-06 2023-01-19 Quorum Innovations, Llc Materials and methods for inhibiting a viral infection, including a coronavirus infection
US20230329989A1 (en) * 2020-09-29 2023-10-19 Conopco, Inc., D/B/A Unilever A personal care composition comprising amino acids
KR102573754B1 (ko) * 2021-02-25 2023-09-01 주식회사 차메디텍 신규의 펩타이드 및 이를 포함하는 피부장벽 강화 또는 피부가려움증 억제를 위한 화장료 조성물
KR102389749B1 (ko) * 2021-05-14 2022-04-22 주식회사 세바바이오텍 피부장벽강화 및 항주름 활성을 갖는 피부 유래 락토바실러스 퍼멘텀 아종 세바­１０１ 균주 및 이의 용도
CN113832050B (zh) * 2021-08-13 2022-10-21 广东省科学院微生物研究所(广东省微生物分析检测中心) 一株高效合成烟酰胺、抗光老化的发酵乳杆菌xjc60及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPS057102A0 (en) * 2002-02-15 2002-03-07 Vri Biomedical Ltd Compositions and methods for treatment of skin disorders
WO2005009342A2 (en) * 2003-07-16 2005-02-03 Pharmacia Corporation Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
EP1736537A1 (en) * 2005-06-22 2006-12-27 OrganoBalance GmbH Methods and means for protecting the skin against pathogenic microorganisms
JP2007284360A (ja) * 2006-04-13 2007-11-01 Mitsukan Group Honsha:Kk 乳酸菌由来のｐｐａｒ依存的遺伝子転写活性化組成物
JP2010511001A (ja) * 2006-12-01 2010-04-08 オルガノバランス ゲーエムベーハー 病原性微生物に対して皮膚を保護するための組成物、キットおよび使用
AU2008333718B2 (en) * 2007-12-06 2012-03-15 Arla Foods Amba Probiotic bacteria and regulation of fat storage
CZ2009724A3 (cs) * 2009-11-04 2011-02-09 Bio Agens Research And Development - Bard, S.R.O. Protiplísnová smes s houbovým organismem Pythium oligandrum
AU2011241175A1 (en) * 2010-04-16 2012-11-29 Davos Life Science Pte. Ltd. Synergistic interaction of at least one Vitamin E component and tyrosinase inhibitors for dermatological applications
AU2012216178A1 (en) * 2011-02-09 2013-08-22 Novozymes A/S Peptide for use in the treatment of skin conditions
EP2680866A1 (en) 2011-03-01 2014-01-08 Quorum Innovations, LLC Materials and methods for treating conditions associated with pathogenic biofilm
CN102226157B (zh) * 2011-05-06 2013-01-09 北京龙科方舟生物工程技术有限公司 一株发酵乳杆菌及其应用
US20140322172A1 (en) 2011-12-07 2014-10-30 Calpis Co., Ltd. Lipid metabolism and/or sugar metabolism improver containing lactic acid bacterium or treatment product thereof
KR102258415B1 (ko) * 2015-07-20 2021-05-28 쿼럼 이노베이션즈 엘엘씨 면역 반응 및 피부 및/또는 점막 장벽 기능을 개선하기 위한 물질 및 방법

Also Published As

Publication number Publication date
HK1253067A1 (zh) 2019-06-06
US10004772B2 (en) 2018-06-26
CA2991990A1 (en) 2017-01-26
US11564957B2 (en) 2023-01-31
WO2017015275A1 (en) 2017-01-26
US9706778B2 (en) 2017-07-18
IL256973B (en) 2020-06-30
AU2016297539A1 (en) 2018-02-08
US20170020139A1 (en) 2017-01-26
US20170296599A1 (en) 2017-10-19
EP3324986B1 (en) 2021-11-24
PT3324986T (pt) 2022-01-26
CN108135947B (zh) 2022-06-14
KR102258415B1 (ko) 2021-05-28
PL3324986T3 (pl) 2022-04-04
IL256973A (en) 2018-03-29
EP3324986A4 (en) 2019-01-09
JP2018527322A (ja) 2018-09-20
CA2991990C (en) 2024-04-16
KR20180023012A (ko) 2018-03-06
ES2904555T3 (es) 2022-04-05
US20200215130A1 (en) 2020-07-09
DK3324986T3 (da) 2022-01-31
CN108135947A (zh) 2018-06-08
US20170224748A1 (en) 2017-08-10
JP6727285B2 (ja) 2020-07-22
AU2016297539B2 (en) 2019-10-31
HUE057494T2 (hu) 2022-05-28
BR112018001187A2 (pt) 2018-09-11
AU2016297539B9 (en) 2019-11-28
US10617726B2 (en) 2020-04-14
EP3324986A1 (en) 2018-05-30
US20230165915A1 (en) 2023-06-01
ZA201800209B (en) 2018-12-19
BR112018001187B1 (pt) 2022-02-15

Similar Documents

Publication Publication Date Title
MX2018000870A (es) Metodos y materiales para mejorar las respuestas inmunitarias y funciones de la barrera de piel y/o mucosa.
IL277648A (en) Medical microbiota for the treatment and/or prevention of food allergy
MX2018004616A (es) Cosmetica qie tiene bacterias probioticas.
WO2016063263A3 (en) Methods and products for modulating microbiota composition for improving the efficacy of a cancer treatment with an immune checkpoint blocker
EP3368071A4 (en) INJECTABLE BOTULINUM TOXIN FORMULAS AND METHODS OF LONG-TERM USE OF THERAPEUTIC OR COSMETIC EFFECT
MX2017009308A (es) Composiciones inmunogenicas para usar en vacunas neumococicas.
EP3536168A3 (en) Probiotic formulations and methods for use
BR112016024352A2 (pt) ?cepa de listeria recombinante, listeria recombinante, composição farmacêutica, e, métodos de induzir uma resposta imune contra um tumor ou um câncer em um indivíduo humano e de listeria?
EP4299122A3 (en) Compositions and methods for treating skin and mucous membrane diseases
PH12017500494A1 (en) Methyl-and trifluoromethyl-substituted pyrrolopyridine modulators of rorc2 and methods of use thereof
EP3474869A4 (en) COMPOSITIONS DERIVED FROM HUMAN TISSUE AND USES THEREOF
MX2018008645A (es) Derivados de 8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano.
PH12018550110A1 (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
EP3518955A4 (en) TERT IMMUNOGENIC COMPOSITIONS AND METHODS OF TREATMENT USING THEM
SG11202005526WA (en) Peptide immunogens of il-31 and formulations thereof for the treatment and/or prevention of atopic dermatitis
MX2018000262A (es) Usos terapeuticos de formulaciones de berberina.
MX2018008640A (es) Derivados de 3-(carboxietil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]- decano.
MX2022009171A (es) Composiciones para el tratamiento de dermatitis atopica canina y sus usos.
EP3636663A4 (en) FGF21 MUTANT HUMAN, ITS PREPARATION PROCESS AND ITS USE
WO2015191449A3 (en) Personal care products containing microalgae or extracts thereof
PH12019550183A1 (en) Treatment of infant colic
MX2017013819A (es) Metodos para la reduccion de grasa.
MX2020001632A (es) Composiciones que comprenden cepas bacterianas.
IL282904A (en) Therapeutic microbiota for the treatment and/or prevention of dysbiosis
EP3664773A4 (en) HAIR TREATMENT COMPOSITIONS AND PROCEDURES